Lamictal®
Lamictal® is a pharmaceutical drug with 12 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
12 of 12 finished
0.0%
0 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions
Clinical Evaluation of BW430C in Epilepsy
Clinical Trials (12)
A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions
Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions
Clinical Evaluation of BW430C in Epilepsy
GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents
Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12